Protecting Your Skin: Wound Care and Surgical Risks
At a Glance
In PASH syndrome, skin trauma can trigger pathergy and turn a minor wound or procedure site into a worsening pyoderma gangrenosum ulcer. Protect wounds with non-adherent dressings and specialist-guided care, and control inflammation before elective procedures.
Managing the skin in PASH syndrome requires a delicate balance. Because your immune system is in a state of high alert, your skin can react to trauma by producing new inflammation rather than healing [1][2]. This response is known as pathergy, and it is the reason why standard surgical and wound care techniques must be carefully modified for you [3].
The Danger of Pathergy in Surgery
In a typical patient, a doctor might “lance” (perform an incision and drainage or I&D) a painful abscess to relieve pressure and infection. However, in PASH, this can be a major hazard [1].
- The Reaction: For someone with PASH, the trauma of the incision can signal the immune system to attack the site. What started as a simple abscess can sometimes quickly transform into an expanding pyoderma gangrenosum (PG) ulcer [1][4].
- Surgical Risk: This risk extends to all types of surgery, including biopsies and elective procedures for hidradenitis suppurativa (HS) [1]. In one small series of patients with both HS and PG, a high percentage developed a new PG ulcer at the surgical site following standard I&D [1].
Because of this, elective surgery is generally avoided while your disease is active. If a procedure is absolutely necessary, it should ideally be performed only after your inflammation is well-controlled by medications [5][6]. However, pathergy risk should never cause you to delay urgent life-saving drainage of a suspected deep or necrotizing infection.
Debridement: A Specialist’s Decision
Debridement is the process of removing dead or infected tissue from a wound to help it heal. Debridement decisions must be made by a specialist team, as even gentle manipulation can sometimes trigger pathergy. You should never attempt to self-debride or “pop” wounds at home [3][7]. What appears to be “dead” tissue may actually be active inflammation or infection requiring specialist care.
Daily Wound Management Principles
Your daily goal is to protect your skin from trauma while managing the fluid (exudate) and pain associated with your ulcers [8][9].
- Atraumatic Care: Always use non-adherent dressings (dressings that won’t stick to the wound bed) as directed by your clinician. When a dressing sticks, removing it can cause minor trauma that triggers pathergy [10].
- Avoid Adhesives: Whenever possible, avoid applying strong adhesive tapes directly to the skin near a wound. Use soft silicone adhesives or wrap-around bandages (like Gauze) to hold dressings in place [10].
- Moisture Balance: PG and HS wounds can produce significant amounts of fluid. Your wound care team may use absorbent foams or specialized moisture-balancing products to keep the wound moist enough to heal but dry enough to prevent the surrounding skin from becoming “soggy” or macerated [11].
- Gentle Cleansing: Avoid scrubbing the wound. Use gentle irrigation with sterile saline or a mild, non-irritating cleanser recommended by your dermatologist [8].
Specialized Tools: NPWT and Grafting
Once the underlying inflammation is calmed by systemic drugs, your care team may use advanced tools to speed up healing:
- Negative-Pressure Wound Therapy (NPWT): Sometimes called a “wound vac,” this uses a vacuum dressing to pull out excess fluid. In PASH, this is almost always used alongside immunosuppressants to prevent it from causing trauma [12][6].
- Skin Grafting: If a large ulcer is stable and no longer “active,” a skin graft can help close the wound. However, this is usually a last resort and is only done when the risk of the “donor site” turning into a new ulcer is low [6][13].
Managing Pain
The pain from PASH ulcers is often described as “out of proportion” to what can be seen [14]. Effective wound care must include a pain management plan, especially during dressing changes [14][15]. This may include topical numbing agents, systemic pain medications, or “pre-medicating” before your daily routine. (If your pain suddenly changes and worsens out of proportion, seek prompt review for infection). Restoring the integrity of the skin through biologics is ultimately the most effective way to resolve this chronic pain [14].
Common questions in this guide
Why can surgery or a biopsy be risky with PASH syndrome?
What should I do if I develop a painful abscess?
What dressings are safest for PASH ulcers?
Should wounds in PASH be debrided?
Can I have surgery or a skin graft if I have PASH?
How can I control pain during PASH dressing changes?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my risk of pathergy, how do you plan to handle any necessary skin procedures like biopsies or debridement?
- 2.If I develop a new painful abscess, can we use an alternative to traditional incision and drainage (I&D) to avoid triggering a PG ulcer?
- 3.Are we coordinating with a specialized wound care team that understands autoinflammatory conditions like PASH?
- 4.What is our plan for perioperative immunosuppression if I ever require surgery for my hidradenitis sinus tracts?
- 5.Which specific non-adherent dressings or moisture-management tools do you recommend for my current ulcers?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Concurrent Hidradenitis Suppurativa and Pyoderma Gangrenosum in a Pediatric Cohort: A Retrospective Case Series.
Wu V, Lara-Corrales I, Sibbald C, Levy R
Journal of cutaneous medicine and surgery 2026; (30(2)):139-142 doi:10.1177/12034754251386763.
PMID: 41189322 - 2
Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
Marzano AV, Damiani G, Ceccherini I, et al.
The British journal of dermatology 2017; (176(6)):1588-1598 doi:10.1111/bjd.15226.
PMID: 27943240 - 3
Wound Debridement in Pyoderma Gangrenosum.
Taheri A, Mansoori P, Sharif M
Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.
PMID: 38241454 - 4
A Case of Overlapping Clinical Features of Idiopathic Granulomatous Mastitis, Hidradenitis Suppurativa, and Pyoderma Gangrenosum Successfully Treated with Adalimumab.
Breznik V, Marko PB
Case reports in dermatology 2022; (14(2)):98-106 doi:10.1159/000523801.
PMID: 35702373 - 5
Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.
Ebrad S, Severyns M, Benzakour A, et al.
International orthopaedics 2018; (42(2)):239-245 doi:10.1007/s00264-017-3672-2.
PMID: 29119297 - 6
Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.
Eisendle K, Thuile T, Deluca J, Pichler M
Advances in wound care 2020; (9(7)):405-425 doi:10.1089/wound.2020.1160.
PMID: 32320362 - 7
An aggressive course of pyoderma gangrenosum mimicking bacterial osteomyelitis after open reduction and internal fixation of a distal radius fracture with a titanium plate.
Wasiak M, Ciszek M, Babiak I, et al.
Reumatologia 2022; (60(4)):292-302 doi:10.5114/reum.2022.119046.
PMID: 36186837 - 8
PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum.
Janowska A, Oranges T, Fissi A, et al.
Dermatologic therapy 2020; (33(3)):e13412 doi:10.1111/dth.13412.
PMID: 32291879 - 9
Pyoderma gangrenosum study pilot registry: The first step to a better understanding.
Orfaly VE, Reese AM, Friedman M, et al.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2022; (30(3)):334-337 doi:10.1111/wrr.13005.
PMID: 35363927 - 10
Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
Afifi L, Sanchez IM, Wallace MM, et al.
Journal of the American Academy of Dermatology 2018; (78(6)):1195-1204.e1 doi:10.1016/j.jaad.2017.12.049.
PMID: 29288099 - 11
Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Nahm WJ, Mota JA, Rojas S, et al.
The American journal of case reports 2018; (19()):844-848 doi:10.12659/AJCR.908995.
PMID: 30022021 - 12
The role of negative pressure wound therapy (NPWT) on the treatment of pyoderma gangrenosum: A systematic review and personal experience.
Almeida IR, Coltro PS, Gonçalves HOC, et al.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2021; (29(3)):486-494 doi:10.1111/wrr.12910.
PMID: 33772964 - 13
Pyoderma gangrenosum following pelvic and femoral osteotomy in an 8-Year-Old Girl with Cri-du-chat syndrome: A case report.
Eugster T, Lengnick H, Lotter L, et al.
JPRAS open 2026; (52()):192-195 doi:10.1016/j.jpra.2026.08.026.
PMID: 42730249 - 14
Updates in innovation of the treatment of pyoderma gangrenosum.
Keum H, Zhivov EV, Ortega-Loayza AG
Expert review of clinical pharmacology 2025; (18(1-2)):29-39 doi:10.1080/17512433.2024.2447776.
PMID: 39720859 - 15
Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF, Grossberg AL, Gaspari AA
Cutis 2015; (95(6)):337-42.
PMID: 26125210
This page provides general information about wound care and procedure risks in PASH syndrome; it is not medical advice. Your dermatologist and wound-care or surgical team should guide dressing changes, debridement, and decisions about procedures.
Get notified when new evidence is published on PASH syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.